Key result
Percutaneous mitral and tricuspid valve devices emerge in ongoing evaluations to treat complex valve pathologies.
Why the study?
There remains a large population of patients with mitral and tricuspid valve disease with unmet clinical needs and complex anatomical challenges requiring unique percutaneous treatment approaches.
This review provides an overview of the rapidly expanding field of percutaneous interventions for complex mitral and tricuspid valve pathologies.
No takes yet. Share an insight, caveat, or question.
Devices remain investigational for complex mitral/tricuspid disease; leaves open which technologies will reach approval and routine use.
Natarajan et al. (2017) conducted a review in Mitral and tricuspid valve disease. Percutaneous mitral and tricuspid valve devices was evaluated. Percutaneous mitral and tricuspid valve devices are emerging to treat complex valve pathologies, with numerous devices currently under preclinical and clinical evaluation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: